Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1145541

registered interest
date	24/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Epilepsy: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the UK leaving the EU without a deal on access to epilepsy medication.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	290454
answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. Our plans should ensure the supply of medicines and medical products when we leave the EU on 31 October.</p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medicines, to the whole of the UK and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 16:50:47 answering member 4362 label Biography information for Edward Argar
tabling member	4510 label Biography information for Helen Hayes

1145542

registered interest
date	24/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect on access to cancer treatment of the UK leaving the EU without an agreement.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	290455
answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. Our plans should ensure the supply of medicines and medical products when we leave the EU on 31 October.</p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medical products to the whole of the UK and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>As with our plans leading up to 29<sup> </sup>March, for those medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes for use in the diagnosis and treatment of cancer, we have asked suppliers to make alternative arrangements, using air freight, which some suppliers are already doing now. We have offered support to companies to arrange this.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 16:54:34 answering member 4362 label Biography information for Edward Argar
tabling member	4510 label Biography information for Helen Hayes

1145575

registered interest
date	24/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Capital Investment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many bids for capital spending (a) his Department, (b) NHS England and (c) NHS Improvement has (i) rejected and (ii) not responded to in each of the last five years; and what the total value was of the bids (A) rejected and (B) not responded to in each of the last five years.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	290466
answer	answer is ministerial correction date of answer 02/10/2019 answer text <p>The information requested on capital bids received by the Department and NHS England and NHS Improvement for capital spending are not held centrally and could only be obtained at disproportionate cost.</p><p>There have been a multitude of capital funds in the last five years varying in value, complexity and outcome objective and NHS England and NHS Improvement are in on-going discussions with trusts about their capital needs and plans.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 290467 question first answered 02/10/2019 12:17:49 answering member 4362 label Biography information for Edward Argar
tabling member	4662 label Biography information for Ruth George

1145576

registered interest
date	24/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Capital Investment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the average length of time was for (a) his Department, (b) NHS England and (c) NHS Improvement to respond to bids for capital spending in each of the last five years.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	290467
answer	answer is ministerial correction date of answer 02/10/2019 answer text <p>The information requested on capital bids received by the Department and NHS England and NHS Improvement for capital spending are not held centrally and could only be obtained at disproportionate cost.</p><p>There have been a multitude of capital funds in the last five years varying in value, complexity and outcome objective and NHS England and NHS Improvement are in on-going discussions with trusts about their capital needs and plans.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 290466 question first answered 02/10/2019 12:17:49 answering member 4362 label Biography information for Edward Argar
tabling member	4662 label Biography information for Ruth George